Carl-Hendrik Heldin

Carl-Hendrik Heldin

Presidente presso
European Molecular Biology Organization
72 anni
Miscellaneous
Consumer Services
Health Technology

Profilo

Carl-Hendrik Heldin is the founder of Mesenkia Therapeutics AB. Current jobs include Chairman at the European Molecular Biology Organization since 2016, Chairman at Science for Life Laboratory since 2013, and Professor at the University of Uppsala since 1992.
Former jobs include Chairman at The Nobel Foundation from 2013 to 2024, Director at Ludwig Institute for Cancer Research Ltd. (Sweden) from 1986 to 2017, Independent Director at Kancera AB from 2012 to 2025, and Vice President at the European Research Council.

Posizioni attive di Carl-Hendrik Heldin

SocietàPosizioneInizio
Corporate Officer/Principal 01/01/1992
Presidente 01/01/2013
European Molecular Biology Organization
Presidente 01/01/2016

Precedenti posizioni note di Carl-Hendrik Heldin

SocietàPosizioneFine
KANCERA AB Direttore/Membro del Consiglio 26/05/2025
Presidente 02/12/2024
Ludwig Institute for Cancer Research Ltd. (Sweden)
Direttore/Membro del Consiglio 01/01/2017
Corporate Officer/Principal 01/01/2014
Vedi nel dettaglio l'esperienza di Carl-Hendrik Heldin

Esperienze
Posizioni ricoperte

Attive

Inattive

Società nel listino

Aziende private

Relazioni

86

Relazioni di 1° grado

7

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Società collegate

Aziende private7

Consumer Services

Miscellaneous

European Molecular Biology Organization

Miscellaneous

Health Technology

Ludwig Institute for Cancer Research Ltd. (Sweden)

Commercial Services

  1. Mercati
  2. Insiders
  3. Carl-Hendrik Heldin